StemSight and ERS Genomics focus on collaboration
License agreement concerns development of cell therapies for corneal blindness
Read More
Tag: blindness
First patient recruited in global AMD trial
The new treatment involves stimulating cells in the retina with light in a process called ‘photobiomodulation.’
Read More
Researchers identify new genes linked to age-related macular degeneration
Fight for Sight has announced a breakthrough in identifying new genes in age-related macular degeneration, the leading cause of blindness.
Read More
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
